Yayın:
Is there any difference in ra patients for methotrexate use vs. leflunomide use as a concomitant treatment with biological and targeted synthetic dmards in turkbio registry?

Placeholder

Tarih

Akademik Birimler

Kurum Yazarları

Dalkılıç, Ediz
Pehlivan, Yavuz

Yazarlar

İnanç, Nevsun
Özen, Gülşen
Yalçınkaya, Yasemin
Koca, Süleyman Serdar
Can, Gerçek
Karataş, Ahmet
Yazıcı, Ayten
Cefle, Ayşe
Tufan, Abdurrahman
Akar, Servet

Danışman

Dil

Türü

Yayıncı:

Wiley

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Özet

Açıklama

Kaynak:

Anahtar Kelimeler:

Konusu

Rheumatology

Alıntı

İnanç, N. vd. (2017). ''Is there any difference in ra patients for methotrexate use vs. leflunomide use as a concomitant treatment with biological and targeted synthetic dmards in turkbio registry?''. Arthritis & Rheumatology, 69(Supplement 10).

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads